C12Y 302/02022
Rrna n-glycosylase
Official title: rRNA N-glycosylase (3.2.2.22)
C12Y302/02022 (Rrna n-glycosylase) appears on 29 US grants and 59 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 59
- Assignees
- 32
- Inventors
- 87
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 1 | 4 |
| 2015 | 2 | 4 |
| 2016 | 2 | 11 |
| 2017 | 2 | 8 |
| 2018 | 6 | 3 |
| 2019 | 1 | 3 |
| 2020 | 2 | 2 |
| 2021 | 1 | 4 |
| 2022 | 4 | 5 |
| 2023 | 1 | 3 |
| 2024 | 3 | 3 |
| 2025 | 1 | 2 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals26 May 2026US 12,637,495 B2Molecular Templates, Inc.
- Genetically encoded protein synthesis inhibitor10 Mar 2026US 12,570,703 B2Max-Planck-Gesellschaft zur Forderung Wissenschaften e.V.
- Plant lectins as carriers of associated drug substances into animal and human cells15 Apr 2025US 12,275,968 B2Biostrategies Lc
- CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors31 Dec 2024US 12,180,262 B2Millennium Pharmaceuticals, Inc.
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals20 Aug 2024US 12,065,469 B2Molecular Templates, Inc.
- Listeria monocytogenes as a vector for tumor-specific delivery of chemotherapeutic agents12 Mar 2026US 2026/0069708 A1Texas Tech University System
- Compositions and methods for treating or preventing neurodegenerative diseases22 Jan 2026US 2026/0021167 A1Delaware State University
- Mutant and mislocalized cell surface nucleophosmin 1 as a diagnostic and therapeutic target of human disease9 Oct 2025US 2025/0313647 A1Cambridge Enterprise Limited
- Plant lectins as carriers of associated drug substances into animal and human cells31 Jul 2025US 2025/0243476 A1Biostrategies Lc
- Mhc class i epitope delivering polypeptides12 Dec 2024US 2024/0409589 A1Molecular Templates, Inc.
Most cited
By later US patents
- Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties22US 10,815,469 B2Molecular Templates, Inc. · 2020
- Targeting ABCB5 for cancer therapy17US 7,928,202 B2The Brigham and Women S Hospital, Inc. · 2011
- Targeting ABCB5 for cancer therapy12US 8,697,072 B2The Brigham and Women S Hospital, Inc. · 2014
- Targeting ABCB5 for cancer therapy10US 9,266,946 B2The Brigham and Women S Hospital, Inc. · 2016
- Antigen binding protein and its use as addressing product for the treatment of cancer9US 9,173,962 B2Pierre Fabre Medicament · 2015